Octreotide Acetate Powder ≥99.5% CAS No: 83150-76-9
Octreotide Acetate Powder ≥99.5% ,Octreotide Acetate Powder,CAS No: 83150-76-9,Octreotide Acetate Powder CAS No: 83150-76-9
Octreotide Acetate - High Purity Research Grade Reagent


Product Name: Octreotide Acetate
Product Purity: ≥99.5% (Research Grade)
CAS No: 83150-76-9
Testing Method: HPLC
Active Ingredient: Octreotide Acetate
Product Characteristics: White to off-white lyophilized powder or sustained-release microsphere preparation (for research)
Product Use: Laboratory pharmaceutical R&D only (not for human/animal use)
Storage Conditions: Refrigerate at 2-8°C, protected from light (unopened)
Shelf Life: 24-36 months (unopened, specific period as indicated on packaging)
Quality Certificate: Complete COA for each batch (research use)
Product Description
Shaanxi Sunrise Pharmaceutical Co., Ltd. provides high-purity Octreotide Acetate research-grade reagent, manufactured under an international standard production system to ensure stable product quality. Our product features a purity of ≥99.5% (validated by HPLC), endotoxin<5EU/mg, and moisture content <5.0%,meeting the stringent requirements of laboratory research.
Available as a white to off-white lyophilized powder or sustained-release microsphere preparation (for research), our Octreotide Acetate exhibits excellent batch stability and solubility. It is designed to meet the research needs of pharmaceutical companies, biotech labs, and academic institutions from early-stage material screening to advanced experimental studies. With strict quality control and a flexible supply chain, we are committed to providing a stable and reliable supply of Octreotide Acetate research reagent to support your scientific endeavors.
Biological Activity (Research Reference Only)
All information below is from public academic literature, for research background reference only – no clinical efficacy claimed.
Hormone Secretion Modulation: In research models, it has been shown to inhibit the secretion of various pituitary hormones and exocrine substances (e.g., growth hormone (GH), insulin, glucagon, gastrin).
Vasoactive Substance Regulation: In experimental studies, it can regulate the release of vasoactive substances (e.g., serotonin, vasoactive intestinal peptide (VIP)).
Cell Proliferation Research: In certain in vitro research models, it has been observed to inhibit the proliferation of specific pathological cell lines (e.g., some neuroendocrine tumor cell lines).
Note: This research reagent is for laboratory use only. The raw material itself does not directly produce clinical efficacy.
Mechanism of Action (Research Reference Only)
Based on public academic research, for laboratory R&D reference only – not applicable to clinical scenarios.
Octreotide Acetate exerts its effects in research models by selectively binding to somatostatin receptors (primarily SSTR2/SSTR5 subtypes):
Signal Pathway Modulation: Inhibits hormone secretion by blocking adenylate cyclase, reducing cAMP levels in the research system.
Cellular Function Research: Activates tyrosine phosphatase and blocks growth factor signaling pathways in experimental cell models.
Vascular Effect Studies: In some research models, it can cause contraction of visceral arterial smooth muscle, a subject of study for its potential effect on portal vein blood flow.
Research Application Scenarios (Laboratory Only)
Research value derived from public academic references – not for clinical application.
| Research Direction | Research Value Reference (Public Literature) |
|---|---|
| Somatostatin Receptor Research | Reference compound for studying SSTR2/SSTR5 binding affinity and selectivity in lab assays. |
| Neuroendocrine Tumor Model Studies | Research tool for investigating effects on cell proliferation and hormone secretion in relevant models. |
| Gastrointestinal & Pancreatic Research | For studying effects on hormone secretion (e.g., gastrin, insulin) and pancreatic enzyme release in experimental systems. |
| Drug Delivery System Research | Active ingredient model for developing and testing sustained-release formulations in the laboratory. |
Core Advantages
Ultra-high Purity: ≥99.5% research-grade purity, validated by HPLC, ensuring high-quality material for sensitive receptor binding studies.
Stringent Quality Control: Endotoxin
Excellent Batch Consistency: Standardized production with strict environmental control, ensuring minimal lot-to-lot variation for reliable results.
Flexible Formulation Options: Available as lyophilized powder or sustained-release microspheres (for research), catering to diverse experimental needs.
Comprehensive COA: Each batch includes a complete Certificate of Analysis for full research traceability and documentation.
Customization Support: Research-oriented customization of specifications and packaging to fit your specific laboratory requirements.
Important Research Use Statement
Usage Restriction: For laboratory pharmaceutical R&D only – prohibited for human/animal clinical use, commercial drug production, or medical diagnosis.
Data Reference: All research data/parameters are from public literature – no guarantee of performance in your specific research system.
Responsibility: Illegal/improper use (e.g., clinical use) leading to research errors or consequences is the user's sole responsibility.
Research Independence: Lab results depend on experimental conditions – no guarantee of alignment with public reference data.
Quality Scope: Research-grade quality only – does not meet commercial drug production/clinical application standards.
